Currently, there are 1.77B common shares owned by the public and among those 1.75B shares have been available to trade.
The company’s stock has a 5-day price change of 1.38% and 16.19% over the past three months. CVX shares are trading 15.50% year to date (YTD), with the 12-month market performance up to 7.00% higher. It has a 12-month low price of $135.37 and touched a high of $168.96 over the same period. CVX has an average intraday trading volume of 7.97 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.59%, 6.31%, and 9.41% respectively.
Institutional ownership of Chevron Corp (NYSE: CVX) shares accounts for 77.33% of the company’s 1.77B shares outstanding.
It has a market capitalization of $292.71B and a beta (3y monthly) value of 0.91. The stock’s trailing 12-month PE ratio is 17.25, while the earnings-per-share (ttm) stands at $9.70. The company has a PEG of 1.68 and a Quick Ratio of 0.83 with the debt-to-equity ratio at 0.19. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.38% over the week and 2.11% over the month.
Analysts forecast that Chevron Corp (CVX) will achieve an EPS of 2.39 for the current quarter, 2.51 for the next quarter and 12.24 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 1.64 while analysts give the company a high EPS estimate of 1.64. Comparatively, EPS for the current quarter was 2.93 a year ago. Earnings per share for the fiscal year are expected to increase by 1.46%, and 17.04% over the next financial year. EPS should shrink at an annualized rate of 10.27% over the next five years, compared to 44.50% over the past 5-year period.
Looking at the support for the CVX, a number of firms have released research notes about the stock. Citigroup stated their Buy rating for the stock in a research note on November 26, 2024, with the firm’s price target at $145-$185. DZ Bank coverage for the Chevron Corp (CVX) stock in a research note released on November 05, 2024 offered a Buy rating with a price target of $170. Bernstein on their part issued Mkt Perform rating on July 17, 2024.
